The latest News

 
8 June 2015
Financial Press Releases
YMAGIS (ISIN : FR0011471291, ticker: MAGIS) , the European specialist in digital technologies for the motion picture industry, announces the closing of R2D1 acquisition, a specialist in the installation and maintenance of digital cinema equipment in France, Switzerland and Africa. YMAGIS acquires...
Read More
 
12 May 2015
Financial Press Releases
YMAGIS (ISIN: FR0011471291, mnemonic: MAGIS) , the specialist in digital technologies for the motion picture industry, today reported its consolidated revenue figures for the first quarter ended March 31, 2015. In the first quarter of 2015, the Group’s revenue amounted to €31.9m, an increase of 77...
Read More
 
20 April 2015
Financial Press Releases
YMAGIS (ISIN: FR0011471291, MNEMONIC: MAGIS) , the specialist in digital technologies for the cinema industry, announces it financial communication agenda for next releases: May 12, 2015 : 2015 Q1 sales June 30, 2015 : Shareholder’s meeting August 4, 2015 : 2015 Q2 sales September 23, 2015 : 2015...
Read More
 
17 April 2015
Financial Press Releases
YMAGIS (ISIN : FR0011471291, mnémo : MAGIS) , le spécialiste des technologies numériques pour l’industrie du cinéma, annonce la publication du rapport financier au 31 décembre 2014. Ce document est disponible sur le site de la société à l’adresse suivante :...
Read More
 
27 March 2015
Financial Press Releases
YMAGIS (ISIN : FR0011471291, mnémo : MAGIS) , le spécialiste des technologies numériques pour l’industrie du cinéma, confirme son éligibilité au PEA-PME conformément au Décret n° 2014-283 du 4 mars 2014 pris pour l'application de l'article 70 de la loi n° 2013-1278 du 29 décembre 2013 de finances...
Read More
 
25 March 2015
Financial Press Releases
YMAGIS (ISIN: FR0011471291, MNEMONIC: MAGIS), the specialist in digital technologies for the cinema industry, released today its financial results for the fiscal year 2014 (FY14); audit procedures currently still underway. Note: During FY14, YMAGIS has acquired the Belgian group dcinex. The...
Read More